The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prospective survey on patient satisfaction and quality-of-life impact concerning the administration of fentanyl pectin nasal spray for breakthrough pain in cancer: Qualipec study.
Ignacio Delgado
Honoraria - Archimedes
Research Funding - Archimedes
Luis Antón-Aparicio
Honoraria - Archimedes
Research Funding - Archimedes
Philippe Poulain
No relevant relationships to disclose
Alain Serrie
No relevant relationships to disclose